Cardiovascular areas we support
The cardiovascular areas we work in, and how our regulatory, clinical, reimbursement and commercial teams support companies in each.
Structural Heart
Transcatheter and surgical therapies for valve and structural disease, adopted through heart teams.
Structural heart devices treat valvular disease and other structural abnormalities through transcatheter and surgical approaches. Adoption runs through multidisciplinary heart teams and depends on imaging, procedural planning, operator experience, hospital capability and follow-up protocols.
How we support
- Regulatory Affairs
PMA and IDE strategy for Class III implants, including label expansion into new anatomies and risk groups.
- Clinical Operations
Pivotal IDE studies with heart-team screening, independent eligibility review and core-laboratory imaging.
- Reimbursement & Market Access
National coverage requirements for TAVR, mitral repair, appendage closure and tricuspid therapies, including registry participation, alongside facility and physician payment.
- Commercial Strategy & Execution
Adoption through structural heart programs: referral pathways, case proctoring and procedural planning support.
Technologies includeTranscatheter aortic valve replacement · Transcatheter mitral and tricuspid repair and replacement · Left atrial appendage closure · Septal defect and PFO closure · Surgical valves and annuloplasty · Embolic protection and procedural imaging
Heart Failure & Circulatory Support
Acute mechanical support, durable devices and remote management across critical care and outpatient follow-up.
This segment covers technologies for acute and chronic heart failure: temporary mechanical circulatory support, durable support systems and monitoring or care-management approaches. They involve different patient populations, care settings, procedural demands and economic models.
How we support
- Regulatory Affairs
Pathways for temporary support, durable devices and implantable monitors, from 510(k) to PMA.
- Clinical Operations
Studies in acutely ill populations and outcomes studies for durable support and remote management.
- Reimbursement & Market Access
Inpatient economics for mechanical support, ventricular assist device coverage (NCD 20.9.1) and payment for remote monitoring.
- Commercial Strategy & Execution
Adoption across shock teams, advanced heart failure programs and outpatient follow-up.
Technologies includeTemporary percutaneous ventricular support · Extracorporeal membrane oxygenation systems · Durable left ventricular assist devices · Implantable hemodynamic monitoring · Device-based heart failure therapies · Remote patient management
Coronary Intervention
Catheter-based treatment and assessment of coronary artery disease in a high-volume, contracted cath lab market.
Coronary intervention covers technologies used to diagnose and treat coronary artery disease through catheter-based procedures, from implants and drug-coated balloons to lesion preparation, intravascular imaging, physiology and tools for complex percutaneous coronary intervention.
How we support
- Regulatory Affairs
510(k), De Novo and PMA pathways for stents, balloons, lesion preparation and intravascular imaging.
- Clinical Operations
Randomized and single-arm studies against established comparators in high-volume PCI centers.
- Reimbursement & Market Access
Hospital outpatient and ambulatory surgery center payment, and new technology payment assessment.
- Commercial Strategy & Execution
Value analysis, contracting and cath lab adoption in a competitive, price-sensitive market.
Technologies includeDrug-eluting stents and scaffolds · Drug-coated balloons · Intravascular lithotripsy and atherectomy · Intravascular imaging (IVUS and OCT) · Coronary physiology · Guides, wires and complex PCI tools
Electrophysiology & Rhythm Management
Ablation, mapping, implantable rhythm devices and monitoring, each with distinct workflows and buyers.
This segment covers ablation technologies, mapping and navigation systems, implantable rhythm-management devices and cardiac monitoring. These categories differ in clinical workflow, evidence requirements, purchasing structure and reimbursement.
How we support
- Regulatory Affairs
PMA and 510(k) strategy across ablation, mapping, implantable rhythm devices and monitors.
- Clinical Operations
Ablation and device studies with procedural, rhythm and durability endpoints.
- Reimbursement & Market Access
Coding and payment for ablation, implant and remote monitoring services, and coverage requirements for implantable defibrillators.
- Commercial Strategy & Execution
Capital and disposable models across EP labs, device clinics and remote monitoring services.
Technologies includePulsed field, radiofrequency and cryoablation · Electroanatomic mapping and navigation · Pacemakers, leadless and conduction system pacing · Implantable cardioverter-defibrillators · Insertable cardiac monitors · Remote device monitoring
Cardiac Surgery & Perfusion
Capital equipment, disposables and surgical technologies evaluated by surgery, perfusion and operating-room leadership.
Cardiac surgery and perfusion encompass technologies used during cardiopulmonary bypass and related surgical procedures, including heart-lung machines, oxygenators, perfusion disposables, monitoring systems and surgical implants. Commercial requirements differ between capital equipment, recurring disposables, procedural technologies and software.
How we support
- Regulatory Affairs
Pathways for perfusion equipment, disposables and surgical implants.
- Clinical Operations
Surgical and perfusion studies, including post-market evidence for disposables and capital systems.
- Reimbursement & Market Access
Inpatient surgical payment and the hospital economics of capital and disposable purchases.
- Commercial Strategy & Execution
Capital sales, disposable contracting and adoption through surgery, perfusion and supply chain.
Technologies includeHeart-lung machines and perfusion systems · Oxygenators, circuits and cannulae · Surgical valves, rings and grafts · Surgical ablation and appendage exclusion · Myocardial protection and blood management · Intraoperative monitoring
Cardiovascular Imaging, Monitoring & Diagnostics
Technologies that characterize the heart and inform decisions, from imaging and physiology to ambulatory monitoring and software.
Cardiovascular imaging, monitoring and diagnostic technologies characterize cardiac structure or function, measure physiologic parameters, detect cardiovascular conditions, support clinical decisions and monitor patients across acute, procedural and ambulatory settings.
How we support
- Regulatory Affairs
510(k) and De Novo strategy, including software and AI-enabled devices.
- Clinical Operations
Diagnostic accuracy and clinical utility studies.
- Reimbursement & Market Access
CPT coding, physician and facility payment for diagnostic services, and coverage for new tests.
- Commercial Strategy & Execution
Adoption across imaging departments, health-system IT and outpatient diagnostic providers.
Technologies includeEchocardiography and intracardiac echo · Cardiac CT and CT-derived physiology · Cardiac MRI and nuclear imaging · ECG and ambulatory rhythm monitoring · Hemodynamic monitoring · AI-enabled analysis software
Vascular & Peripheral Intervention
Endovascular and surgical technologies across arterial, aortic and venous disease, often used in several sites of care.
Vascular and peripheral intervention covers technologies used in endovascular procedures and the treatment of peripheral arterial, aortic and venous disease. Products vary by anatomy, procedure, setting, user and whether they are implantable, disposable, capital-based or software-enabled.
How we support
- Regulatory Affairs
Pathways for peripheral, aortic and venous devices, from 510(k) to PMA.
- Clinical Operations
Studies with patency, limb-salvage and durability endpoints.
- Reimbursement & Market Access
Site-of-service payment across hospital, ambulatory surgery center and office-based lab settings.
- Commercial Strategy & Execution
Adoption across vascular surgery, interventional radiology, cardiology and office-based labs.
Technologies includePeripheral drug-coated balloons and stents · Atherectomy and intravascular lithotripsy · Aortic stent grafts · Venous thrombectomy and venous stents · Carotid revascularization · Embolic protection and closure devices
Working on a cardiovascular device?
Tell us about the technology and where it is in development.

